Related references
Note: Only part of the references are listed.A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist
Juliet Mwirigi et al.
JOURNAL OF PAIN (2021)
Molecular mechanisms regulating Proteinase-Activated Receptors (PARs)
Arundhasa Chandrabalan et al.
FEBS JOURNAL (2021)
Protease Activated Receptors and Arthritis
Flora Lucena et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4)
Pierre E. Thibeault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Osteoarthritis year in review 2019: epidemiology and therapy
M. Kloppenburg et al.
OSTEOARTHRITIS AND CARTILAGE (2020)
Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017
Saeid Safiri et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease
Allison C. Billi et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Role of the Helix-8 and C-Terminal Tail in Regulating Proteinase Activated Receptor 2 Signaling
Pierre E. Thibeault et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Serine proteinases in the turnover of the cartilage extracellular matrix in the joint: implications for therapeutics
David J. Wilkinson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
N-Cinnamoylanthranilates as human TRPA1 modulators: Structure-activity relationships and channel binding sites
Arundhasa Chandrabalan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2018)
Proteinases and their receptors in inflammatory arthritis: an overview
Katerina Oikonomopoulou et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
A novel mechanism regulating human platelet activation by MMP-2-mediated PAR1 biased signaling
Manuela Sebastiano et al.
BLOOD (2017)
Protease-Mediated Suppression of DRG Neuron Excitability by Commensal Bacteria
Jessica L. Sessenwein et al.
JOURNAL OF NEUROSCIENCE (2017)
Targeting a Proteinase-Activated Receptor 4 (PAR4) Carboxyl Terminal Motif to Regulate Platelet Function
Rithwik Ramachandran et al.
MOLECULAR PHARMACOLOGY (2017)
Proteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathology
Carmen Huesa et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Silencing of protease-activated receptors attenuates synovitis and cartilage damage following a joint bleed in haemophilic mice
L. Nieuwenhuizen et al.
HAEMOPHILIA (2016)
ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
Maria Raffaella Zocchi et al.
ONCOIMMUNOLOGY (2016)
Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets
Ines Ambite et al.
PLOS PATHOGENS (2016)
Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling
Koichiro Mihara et al.
MOLECULAR PHARMACOLOGY (2016)
Cathepsin S Causes Inflammatory Pain via Biased Agonism of PAR2 and TRPV4
Peishen Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Depletion of Protease-Activated Receptor 2 but Not Protease-Activated Receptor 1 May Confer Protection Against Osteoarthritis in Mice Through Extracartilaginous Mechanisms
Miriam T. Jackson et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Biased signaling of protease-activated receptors
Peishen Zhao et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Neutrophil Elastase and Proteinase-3 Trigger G Protein-biased Signaling through Proteinase-activated Receptor-1 (PAR1)
Koichiro Mihara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Diagnostic and prognostic value of bone biomarkers in progressive knee osteoarthritis: a 6-year follow-up study in middle-aged subjects
J. Kumm et al.
OSTEOARTHRITIS AND CARTILAGE (2013)
Genetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug Targets
Rachel E. Miller et al.
CURRENT RHEUMATOLOGY REPORTS (2013)
Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis
Meilang Xue et al.
ARTHRITIS AND RHEUMATISM (2012)
Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)
J. Y. Suen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Targeting proteinase-activated receptors: therapeutic potential and challenges
Rithwik Ramachandran et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Correlation of protease-activated receptor-2 expression and synovitis in rheumatoid and osteoarthritis
Alistair G. Tindell et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Neutrophil Elastase Acts as a Biased Agonist for Proteinase-activated Receptor-2 (PAR2)
Rithwik Ramachandran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Structure, function and pathophysiology of protease activated receptors
Mark N. Adams et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Proteinase-Activated Receptor-4 (PAR(4)) Activation Leads to Sensitization of Rat Joint Primary Afferents Via a Bradykinin B-2 Receptor-Dependent Mechanism
Fiona A. Russell et al.
JOURNAL OF NEUROPHYSIOLOGY (2010)
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
Jeremie Sellam et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Triggering of Proteinase-Activated Receptor 4 Leads to Joint Pain and Inflammation in Mice
Jason J. McDougall et al.
ARTHRITIS AND RHEUMATISM (2009)
Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site
Vishal Trivedi et al.
CELL (2009)
Protease-activated receptor-4 (PAR4): a role as inhibitor of visceral pain and hypersensitivity
C. Auge et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
A peptide hydroxamate library for enrichment of metalloproteinases: towards an affinity-based metalloproteinase profiling protocol
Paul Geurink et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site
Marvin T. Nieman et al.
BIOCHEMISTRY (2007)
Membrane-type serine protease-1/matriptase induces interleukin-6 and-8 in endothelial cells by activation of protease-activated receptor-2 -: Potential implications in atherosclerosis
Isabell Seitz et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4
Rithwik Ramachandran et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium - Ex vivo studies using a novel proteinase-activated receptor 2 antagonist
Elizabeth B. Kelso et al.
ARTHRITIS AND RHEUMATISM (2007)
Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study
Christelle Boileau et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Proteinases in the joint: clinical relevance of proteinases in joint destruction
Yvonne Rengel et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Design and synthesis of an orally active matrix metalloproteinase inhibitor
Shingo Yamamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Role of matrix metalloproteinases in intestinal inflammation
Carlos Medina et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Matrix metalloproteinases: Role in arthritis
PS Burrage et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Urokinase-type plasminogen activator, an endogenous antibiotic
T Jin et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1
JN McLaughlin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells
S Dulon et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Reduction of arthritis severity in protease-activated receptor-deficient mice
YH Yang et al.
ARTHRITIS AND RHEUMATISM (2005)
A genomic analysis of rat proteases and protease inhibitors
XS Puente et al.
GENOME RESEARCH (2004)
Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme
U Neumann et al.
ANALYTICAL BIOCHEMISTRY (2004)
Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors
A Magklara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The proteinase-activated receptor 2 is involved in nociception
WA Hoogerwerf et al.
JOURNAL OF NEUROSCIENCE (2001)
Glycosylation and the activation of proteinase-activated receptor 2 (PAR2) by human mast cell tryptase
SJ Compton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Role for matrix metalloproteinase 9 after focal cerebral ischemia, effects of gene knockout and enzyme inhibition with BB-94
M Asahi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Cathepsin G activates protease-activated receptor-4 in human platelets
GR Sambrano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
